35 results on '"Singeap, Ana-Maria"'
Search Results
2. Investigating the Impact of Nutrition and Oxidative Stress on Attention Deficit Hyperactivity Disorder.
- Author
-
Visternicu, Malina, Rarinca, Viorica, Burlui, Vasile, Halitchi, Gabriela, Ciobică, Alin, Singeap, Ana-Maria, Dobrin, Romeo, Mavroudis, Ioannis, and Trifan, Anca
- Abstract
Background/Objectives: Attention deficit hyperactivity disorder (ADHD) is the most common childhood-onset neurodevelopmental disorder, characterized by difficulty maintaining attention, impulsivity, and hyperactivity. While the cause of this disorder is still unclear, recent studies have stated that heredity is important in the development of ADHD. This is linked to a few comorbidities, including depression, criminal behavior, and anxiety. Although genetic factors influence ADHD symptoms, there are also non-genetic factors, one of which is oxidative stress (OS), which plays a role in the pathogenesis and symptoms of ADHD. This review aims to explore the role of OS in ADHD and its connection to antioxidant enzyme levels, as well as the gut–brain axis (GBA), focusing on diet and its influence on ADHD symptoms, particularly in adults with comorbid conditions. Methods: The literature search included the main available databases (e.g., Science Direct, PubMed, and Google Scholar). Articles in the English language were taken into consideration and our screening was conducted based on several words such as "ADHD", "oxidative stress", "diet", "gut–brain axis", and "gut microbiota." The review focused on studies examining the link between oxidative stress and ADHD, the role of the gut–brain axis, and the potential impact of dietary interventions. Results: Oxidative stress plays a critical role in the development and manifestation of ADHD symptoms. Studies have shown that individuals with ADHD exhibit reduced levels of key antioxidant enzymes, including glutathione peroxidase (GPx), catalase (CAT), and superoxide dismutase (SOD), as well as a diminished total antioxidant status (TOS) compared to healthy controls. Additionally, there is evidence of a close bidirectional interaction between the nervous system and gut microbiota, mediated by the gut–brain axis. This relationship suggests that dietary interventions targeting gut health may influence ADHD symptoms and related comorbidities. Conclusions: Oxidative stress and the gut–brain axis are key factors in the pathogenesis of ADHD, particularly in adults with comorbid conditions. A better understanding of these mechanisms could lead to more targeted treatments, including dietary interventions, to mitigate ADHD symptoms. Further research is required to explore the therapeutic potential of modulating oxidative stress and gut microbiota in the management of ADHD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Impact of Treatment with Direct Antivirals on Coagulation Parameters in Patients with Hepatitis C Virus-Related Liver Cirrhosis and Sustained Virological Response.
- Author
-
Huiban, Laura, Stanciu, Carol, Muzica, Cristina Maria, Girleanu, Irina, Avram, Raluca, Damian, Ioana, Nastasa, Robert, Stratina, Ermina, Zenovia, Sebastian, Minea, Horia, Stafie, Remus, Rotaru, Adrian, Singeap, Ana-Maria, Chiriac, Stefan, Balmus, Ioana-Miruna, and Trifan, Anca
- Subjects
CHRONIC hepatitis C ,CIRRHOSIS of the liver ,BLOOD coagulation ,END of treatment ,HEPATITIS C - Abstract
Background and Objectives: Sustained virologic responses (SVRs) lead to a decrease in portal hypertension, the regression of fibrosis, and the improvement in the hepatic synthesis of procoagulant and anticoagulant factors. We aimed to assess the influence of SVR on coagulation parameters in cirrhotic patients with HCV treated with DAAs. Methods: We performed a prospective study in the Institute of Gastroenterology and Hepatology Iasi, Romania, between January 2022 and February 2024. We included patients diagnosed with compensated and decompensated HCV-related liver cirrhosis, treated with direct antivirals (PrOD ± RBV or SOF/LED ± RBV) for 12/24 weeks. Blood samples for biochemical, immunological, and coagulation tests were collected at the baseline, end of treatment (EOT), and once sustained virological response had been achieved over a period of 12/24 weeks (SVR12/24). Results: We analyzed a group of 52 patients with HCV-related liver cirrhosis, predominantly female (68.0%), and the degree of severity of cirrhosis placed the patients mainly in Child–Pugh classes B (40%) and C (36%). All patients achieved SVRs. The MELD score decreased at EOT (13.48 ± 4.273; p = 0.001) and SVR (9.88 ± 2.774; p = 0.000), compared to the baseline (14.92 ± 4.707). The FibroScan values decreased at SVR (17.596 ± 3.7276; p = 0.000) compared to the baseline (26.068 ± 7.0954). For all common coagulation parameters (platelets, INR, PT, fibrinogen, aPTT), there was a trend towards improvement during treatment, including changes which were statistically significant for the majority of patients. Factor II was low at the baseline (75.40 ± 7.506) but increased at EOT (87.40 ± 9.587) and, later, at SVR (99.12 ± 11.695; p = 0.000). The FVIII values increased at the baseline (175.52 ± 16.414) and decreased at EOT (151.48 ± 13.703) and SVR (143.40 ± 13.937). The FvW values decreased during treatment (146.84 ± 9.428, at baseline; 141.32 ± 9.690, p = 0.000, at EOT; and 126.68 ± 17.960, at SVR). In regard to the anticoagulant factors (PC, PS, ATIII), a significant improvement was brought on by SVR. Advanced stages of liver disease showed the most diminished FII activity, while at the baseline and in Child–Pugh C patients we recorded the highest values of FVIII and FvW. Conclusions: Our study proved that the "reset" of coagulopathy might be due to the improvement in liver function due to viral eradication secondary to AAD therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. The Contribution of Genetic and Epigenetic Factors: An Emerging Concept in the Assessment and Prognosis of Inflammatory Bowel Diseases.
- Author
-
Minea, Horia, Singeap, Ana-Maria, Minea, Manuela, Juncu, Simona, Muzica, Cristina, Sfarti, Catalin Victor, Girleanu, Irina, Chiriac, Stefan, Miftode, Ioana Diandra, Stanciu, Carol, and Trifan, Anca
- Subjects
- *
EPIGENOMICS , *MULTIOMICS , *GENOMICS , *PROGNOSIS , *INDIVIDUALIZED medicine , *INFLAMMATORY bowel diseases - Abstract
Inflammatory bowel disease (IBD) represents heterogeneous and relapsing intestinal conditions with a severe impact on the quality of life of individuals and a continuously increasing prevalence. In recent years, the development of sequencing technology has provided new means of exploring the complex pathogenesis of IBD. An ideal solution is represented by the approach of precision medicine that investigates multiple cellular and molecular interactions, which are tools that perform a holistic, systematic, and impartial analysis of the genomic, transcriptomic, proteomic, metabolomic, and microbiomics sets. Hence, it has led to the orientation of current research towards the identification of new biomarkers that could be successfully used in the management of IBD patients. Multi-omics explores the dimension of variation in the characteristics of these diseases, offering the advantage of understanding the cellular and molecular mechanisms that affect intestinal homeostasis for a much better prediction of disease development and choice of treatment. This review focuses on the progress made in the field of prognostic and predictive biomarkers, highlighting the limitations, challenges, and also the opportunities associated with the application of genomics and epigenomics technologies in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Oral Health and "Modern" Digestive Diseases: Pathophysiologic and Etiologic Factors.
- Author
-
Rotaru, Mihaela, Singeap, Ana-Maria, Ciobica, Alin, Huiban, Laura, Stanciu, Carol, Romila, Laura, Burlui, Vasile, Mavroudis, Ioannis, and Trifan, Anca
- Subjects
DIGESTIVE system diseases ,SMALL intestinal bacterial overgrowth ,INFLAMMATORY bowel diseases ,NON-alcoholic fatty liver disease ,MEDICAL personnel - Abstract
In the contemporary era of medicine, exploring the complexity of the human body and its intricate interactions has become a central concern for health researchers. The main purpose of this article is to summarize the current understanding of relevant pathophysiological factors such as chronic inflammation, dysbiosis (microbial imbalance), and metabolic disorders, as well as etiological factors including dietary habits, lifestyle choices, obesity, metabolic syndrome, and genetic predispositions, as well as to emphasize potential avenues for upcoming studies and their medical significance. Additionally, this article aims to assess the potential impact of integrated treatment approaches on patient outcomes, emphasizing the need for interdisciplinary collaboration between gastroenterologists, dentists, and other healthcare professionals to develop comprehensive care plans that address both oral and digestive health issues simultaneously. Among the branches with a significant impact on general well-being are oral cavity health and digestive diseases, which have been the subject of intensive research in recent decades. In this context, analysis of the current state of knowledge on oral cavity disorders in relation to "modern" digestive diseases such as non-alcoholic fatty liver disease (NAFLD), small intestinal bacterial overgrowth (SIBO), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS) becomes essential for a deeper understanding of the interconnections between oral and digestive health. The temporal overlap or succession, whether preceding or following, of oral manifestations and digestive disorders should be taken seriously by both gastroenterologists and dentists to facilitate early diagnosis and explain to patients the correlation between these two body systems. In summary, this article underscores the importance of understanding the intricate relationship between oral and digestive health, advocating for interdisciplinary approaches to improve patient outcomes and guide future research. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Bridging the gap: Unveiling the crisis of physical inactivity in inflammatory bowel diseases
- Author
-
Stafie, Remus, primary, Singeap, Ana-Maria, additional, Rotaru, Adrian, additional, Stanciu, Carol, additional, and Trifan, Anca, additional
- Published
- 2024
- Full Text
- View/download PDF
7. New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease.
- Author
-
Stratina, Ermina, Stanciu, Carol, Nastasa, Robert, Zenovia, Sebastian, Stafie, Remus, Rotaru, Adrian, Cuciureanu, Tudor, Muzica, Cristina, Sfarti, Catalin, Girleanu, Irina, Minea, Horia, Petrea, Oana, Huiban, Laura, Chiriac, Stefan, Singeap, Ana-Maria, Vlad, Oana, Cojocariu, Camelia, and Trifan, Anca
- Subjects
HEPATIC fibrosis ,TYPE 2 diabetes ,WAIST-hip ratio ,SEMAGLUTIDE ,BODY mass index - Abstract
Background and aims: Increases in both the prevalence and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity are closely related. Type 2 diabetes (T2DM) has been associated with metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis and hepatocellular carcinoma. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for the treatment of T2DM and has an important role in weight loss. Also, it may represent a new therapeutic option for the treatment of MASH in obese diabetic patients. The main outcomes were changes from baseline in liver steatosis and fibrosis at week 24. Material and methods: A total of one hundred eighty-seven patients with T2DM were eligible for this prospective study; ninety-five subjects were treated with oral semaglutide, and ninety-two patients were treated with dapagliflozin as an add-on to metformin. All the subjects were evaluated using Vibration Controlled Transient Elastography (VCTE) from June to December 2022. Results: From our cohort, 54% of the patients were females, with a mean age of 59.92 ± 11.89 years and a mean body mass index (BMI) of 29.53 ± 5.33 kg/m
2 . Following a six-month medication period, we observed a substantial reduction in anthropometric measurements, including the BMI, waist circumference (WC), and waist-to-hip ratio (WtHr), in both groups. Regarding HbA1c, a notable decrease was observed in the semaglutide group (p < 0.001) when compared to the dapagliflozin group (p = 0.011). In addition, the liver stiffness measurement (LSM) according to VCTE improved significantly in the semaglutide group participants from 8.07 ± 2.90 kPa at baseline to 6.51 ± 3.09 kPa after medication (p < 0.001). Conclusion: The superior metabolic effects of semaglutide, correlated to dapagliflozin, may contribute to a more efficient decrease in hepatic stress and injury, leading to a substantial enhancement of liver function in T2DM patients. Further investigations conducted over an ideal timeframe are necessary to confirm the evidence presented in this study. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
8. Clinical Implications and Management of Spontaneous Portosystemic Shunts in Liver Cirrhosis.
- Author
-
Juncu, Simona, Minea, Horia, Girleanu, Irina, Huiban, Laura, Muzica, Cristina, Chiriac, Stefan, Timofeiov, Sergiu, Mihai, Florin, Cojocariu, Camelia, Stanciu, Carol, Trifan, Anca, and Singeap, Ana-Maria
- Subjects
MAGNETIC resonance imaging ,HEPATIC encephalopathy ,LIVER diseases ,CIRRHOSIS of the liver ,LIVER transplantation - Abstract
Portal hypertension from chronic liver disease leads to the formation of collateral blood vessels called spontaneous portosystemic shunts (SPSS). These shunts may form from existing vessels or through neo-angiogenesis. Their location affects clinical outcomes due to varying risks and complications. This review summarizes current knowledge on SPSS, covering their clinical impact and management strategies. Recent data suggest that SPSS increases the risk of variceal bleeding, regardless of shunt size. The size of the shunt is crucial in the rising incidence of hepatic encephalopathy (HE) linked to SPSS. It also increases the risk of portopulmonary hypertension and portal vein thrombosis. Detecting and assessing SPSS rely on computed tomography (CT) and magnetic resonance imaging. CT enables precise measurements and the prediction of cirrhosis progression. Management focuses on liver disease progression and SPSS-related complications, like HE, variceal bleeding, and portopulmonary hypertension. Interventional radiology techniques such as balloon-occluded, plug-assisted, and coil-assisted retrograde transvenous obliteration play a pivotal role. Surgical options are rare but are considered when other methods fail. Liver transplantation (LT) often resolves SPSS. Intraoperative SPSS ligation is still recommended in patients at high risk for developing HE or graft hypoperfusion. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Insights into the Natural and Treatment Courses of Hepatitis B in Children: A Retrospective Study.
- Author
-
Forna, Lorenza, Bozomitu, Laura, Lupu, Ancuta, Lupu, Vasile Valeriu, Cojocariu, Camelia, Anton, Carmen, Girleanu, Irina, Singeap, Ana Maria, Muzica, Cristina Maria, and Trifan, Anca
- Subjects
CHRONIC active hepatitis ,HEPATITIS B ,VIRAL hepatitis ,HEPATITIS B virus ,CHILD patients - Abstract
Chronic Hepatitis B virus (HBV) infection in children remains a significant public health challenge. The natural history and treatment outcomes of HBV can vary widely, influencing management strategies. This retrospective study was conducted in Northeast Romania and involved a cohort of 148 pediatric patients diagnosed with chronic viral Hepatitis B. Of these, 59 children underwent antiviral treatment while 89 were not treated. One of the main objectives was the rate of HBeAg (Hepatitis B-e antigen) seroconversion, a marker of disease progression and response to therapy. Among the treated group, 26 children (44%) achieved HBeAg seroconversion following therapy. In contrast, 44 of the untreated children (49%) experienced spontaneous HBeAg seroconversion, indicating a substantial rate of natural resolution within this population subset. The findings highlight a significant proportion of spontaneous seroconversion in untreated pediatric patients, suggesting a potential re-evaluation of treatment criteria and timing for children with chronic HBV infection. The comparable rates of seroconversion between treated and untreated cohorts underscore the need for individualized treatment approaches based on a combination of virological, biochemical, and clinical parameters. Further studies are required to refine management strategies to optimize long-term outcomes in pediatric HBV infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. The Impact of Alcohol Consumption Pattern on Liver Fibrosis in Asymptomatic Patients
- Author
-
Minea, Horia, primary, Singeap, Ana-Maria, additional, Sfarti, Catalin Victor, additional, Girleanu, Irina, additional, Chiriac, Stefan, additional, Muzica, Cristina, additional, Cuciureanu, Tudor, additional, Petrea, Oana Cristina, additional, Huiban, Laura, additional, Zenovia, Sebastian, additional, Nastasa, Robert, additional, Rotaru, Adrian, additional, Stafie, Remus, additional, Stratina, Ermina, additional, Cojocariu, Camelia, additional, Stanciu, Carol, additional, and Trifan, Anca, additional
- Published
- 2023
- Full Text
- View/download PDF
11. Small Bowel Capsule Endoscopy and Enteroscopy: A Shoulder-to-Shoulder Race
- Author
-
Singeap, Ana-Maria, primary, Sfarti, Catalin, additional, Minea, Horia, additional, Chiriac, Stefan, additional, Cuciureanu, Tudor, additional, Nastasa, Robert, additional, Stanciu, Carol, additional, and Trifan, Anca, additional
- Published
- 2023
- Full Text
- View/download PDF
12. Reclassification of Inflammatory Bowel Disease Type Unclassified by Small Bowel Capsule Endoscopy
- Author
-
Singeap, Ana-Maria, primary, Sfarti, Catalin, additional, Girleanu, Irina, additional, Huiban, Laura, additional, Muzica, Cristina, additional, Timofeiov, Sergiu, additional, Stanciu, Carol, additional, and Trifan, Anca, additional
- Published
- 2023
- Full Text
- View/download PDF
13. Real-World Utilization of Corticosteroids in Severe Alcoholic Hepatitis: Eligibility, Response, and Outcomes.
- Author
-
Singeap, Ana-Maria, Minea, Horia, Petrea, Oana, Robea, Madalina-Andreea, Balmuș, Ioana-Miruna, Duta, Raluca, Ilie, Ovidiu-Dumitru, Cimpoesu, Carmen Diana, Stanciu, Carol, and Trifan, Anca
- Subjects
HEPATITIS ,GASTROINTESTINAL hemorrhage ,DEATH rate ,PEOPLE with alcoholism ,CORTICOSTEROIDS ,MEDICAL personnel - Abstract
Background and Objectives: Alcoholic hepatitis (AH) poses a medical challenge, causing moderately severe to life-threatening episodes with high short- and long-term mortality. This study aimed to explore real-world corticosteroid utilization in severe AH, response predictors, and patient outcomes. Materials and Methods: We conducted a retrospective study on patients admitted for severe AH, defined as a Maddrey Discriminant Function score equal to or above 32, at a tertiary care center. We reviewed patients' medical observation charts to identify corticosteroid prescriptions, reasons for ineligibility, and response rates. Responders were defined based on the Lille score, and predictors of non-response were identified. Short-term (one-month) and long-term (one-year) mortality rates were calculated according to treatment and response. Results: Out of 310 patients enrolled with severe AH, 59% received corticosteroids, achieving a response rate of 75.4%. The reasons for not administering corticosteroids were as follows: uncontrolled infections (27.6%), renal dysfunction (20.4%), gastrointestinal bleeding (18.9%), acute pancreatitis (7.1%), uncontrolled diabetes (3.1%), and other or unknown causes (22.8%). The overall 1-month mortality rate was 12.2%, higher in non-responders (35.3%) and patients who did not receive corticosteroids (13.4%) compared to responders (3.6%). The overall 1-year mortality rate was 62.5%, similar between patients who did not receive corticosteroids (78.7%) and non-responders (77.7%) and higher compared to responders (42.8%). Predictive factors for non-response included older age (OR = 1.05, 95%CI: 1.01–1.08), concomitant cirrhosis (OR= 2.11, 95% CI: 1.064–4.20), MELD scores exceeding 30 (OR = 2.42, 95% CI: 1.21–4.80), severe hypoalbuminemia (OR = 2.46, 95%CI: 1.12–5.37), and increased serum creatinine (OR = 1.5, 95% CI: 1.1–2.03). Among the prognostic scores, MELD 3.0 score exhibited superior efficacy for short-term (AUC = 0.734, 95% CI 0.656–0.811) and long-term mortality (AUC = 0.777, 95% CI: 0.724–0.830) compared to alternative scoring systems. Conclusions: Low eligibility rate and poor prognosis underscore the need for effective therapies. Our findings contribute to refining risk stratification and early prediction of non-response, aiding clinicians in identifying more beneficial therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy—A New Potential Therapeutic Target in Inflammatory Bowel Disease
- Author
-
Chiriac, Stefan, primary, Sfarti, Catalin Victor, additional, Minea, Horia, additional, Stanciu, Carol, additional, Cojocariu, Camelia, additional, Singeap, Ana-Maria, additional, Girleanu, Irina, additional, Cuciureanu, Tudor, additional, Petrea, Oana, additional, Huiban, Laura, additional, Muzica, Cristina Maria, additional, Zenovia, Sebastian, additional, Nastasa, Robert, additional, Stafie, Remus, additional, Rotaru, Adrian, additional, Stratina, Ermina, additional, and Trifan, Anca, additional
- Published
- 2023
- Full Text
- View/download PDF
15. Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
- Author
-
Trifan, Anca, primary, Cuciureanu, Tudor, additional, Nastasa, Robert, additional, Stratina, Ermina, additional, Zenovia, Sebastian, additional, Muzica, Cristina Maria, additional, Huiban, Laura, additional, Singeap, Ana-Maria, additional, Chiriac, Stefan, additional, Sfarti, Catalin, additional, Cojocariu, Camelia, additional, Girleanu, Irina, additional, Minea, Horia, additional, Stafie, Remus, additional, Rotaru, Adrian, additional, and Stanciu, Carol, additional
- Published
- 2023
- Full Text
- View/download PDF
16. Improvement of carotid atherosclerosis and peripheral artery disease after hepatitis C virus eradication by direct-acting antivirals.
- Author
-
CUCIUREANU, TUDOR, STANCIU, CAROL, NĂSTASĂ, ROBERT RADU, STRATINA, LARISA ERMINA, MINEA, HORIA OCTAV, ZENOVIA, IOAN SEBASTIAN, SFARTI, CĂTĂLIN, MUZICA, CRISTINA MARIA, HUIBAN, LAURA, STAFIE, REMUS THEODOR, SINGEAP, ANA-MARIA, CHIRIAC, ŞTEFAN, COJOCARIU, ELIZA CAMELIA, GÎRLEANU, IRINA, PETREA, OANA CRISTINA, TIMOFEIOV, SERGIU, CUCIUREANU, IULIAN DAN, ROTARU, ADRIAN, and TRIFAN, ANCA
- Published
- 2023
- Full Text
- View/download PDF
17. High prevalence of liver fibrosis among general population: a Romanian population-based study
- Author
-
Trifan, Anca, primary, Muzica, Cristina-Maria, additional, Nastasa, Robert, additional, Zenovia, Sebastian, additional, Stratina, Ermina, additional, Stafie, Remus, additional, Rotaru, Adrian, additional, Singeap, Ana-Maria, additional, Cojocariu, Camelia, additional, Sfarti, Catalin, additional, Girleanu, Irina, additional, Chiriac, Stefan, additional, Cuciureanu, Tudor, additional, Huiban, Laura, additional, and Stanciu, Carol, additional
- Published
- 2023
- Full Text
- View/download PDF
18. Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis
- Author
-
Trifan, Anca, primary, Minea, Horia, additional, Rotaru, Adrian, additional, Stanciu, Carol, additional, Stafie, Remus, additional, Stratina, Ermina, additional, Zenovia, Sebastian, additional, Nastasa, Robert, additional, Singeap, Ana-Maria, additional, Girleanu, Irina, additional, Muzica, Cristina, additional, Huiban, Laura, additional, Cuciureanu, Tudor, additional, Chiriac, Stefan, additional, Sfarti, Catalin, additional, and Cojocariu, Camelia, additional
- Published
- 2022
- Full Text
- View/download PDF
19. Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter
- Author
-
Trifan, Anca, primary, Stafie, Remus, additional, Rotaru, Adrian, additional, Stratina, Ermina, additional, Zenovia, Sebastian, additional, Nastasa, Robert, additional, Huiban, Laura, additional, Cuciureanu, Tudor, additional, Muzica, Cristina, additional, Chiriac, Stefan, additional, Girleanu, Irina, additional, Singeap, Ana-Maria, additional, Sfarti, Catalin, additional, Cojocariu, Camelia, additional, Petrea, Oana, additional, and Stanciu, Carol, additional
- Published
- 2022
- Full Text
- View/download PDF
20. Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter
- Author
-
Trifan, Anca, primary, Stratina, Ermina, additional, Nastasa, Robert, additional, Rotaru, Adrian, additional, Stafie, Remus, additional, Zenovia, Sebastian, additional, Huiban, Laura, additional, Sfarti, Catalin, additional, Cojocariu, Camelia, additional, Cuciureanu, Tudor, additional, Muzica, Cristina, additional, Chiriac, Stefan, additional, Girleanu, Irina, additional, Singeap, Ana-Maria, additional, and Stanciu, Carol, additional
- Published
- 2022
- Full Text
- View/download PDF
21. Improved recurrence-free survival rates in patients with HCV-related hepatocellular carcinoma and sustained virological response to direct-acting antivirals
- Author
-
Muzica, Cristina-Maria, primary, Trifan, Anca, additional, Huiban, Laura, additional, Stoica, Oana, additional, Girleanu, Irina, additional, Chiriac, Stefan, additional, Singeap, Ana-Maria, additional, Cojocariu, Camelia, additional, Cuciureanu, Tudor, additional, Zenovia, Sebastian, additional, Nastasa, Robert, additional, and Stanciu, Carol, additional
- Published
- 2022
- Full Text
- View/download PDF
22. Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological Response
- Author
-
Trifan, Anca, primary, Stratina, Ermina, additional, Rotaru, Adrian, additional, Stafie, Remus, additional, Zenovia, Sebastian, additional, Nastasa, Robert, additional, Huiban, Laura, additional, Sfarti, Catalin, additional, Cojocariu, Camelia, additional, Cuciureanu, Tudor, additional, Muzica, Cristina, additional, Chiriac, Stefan, additional, Girleanu, Irina, additional, Singeap, Ana-Maria, additional, and Stanciu, Carol, additional
- Published
- 2022
- Full Text
- View/download PDF
23. The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students
- Author
-
Nastasa, Robert, primary, Stanciu, Carol, additional, Zenovia, Sebastian, additional, Singeap, Ana-Maria, additional, Cojocariu, Camelia, additional, Sfarti, Catalin, additional, Girleanu, Irina, additional, Chiriac, Stefan, additional, Cuciureanu, Tudor, additional, Huiban, Laura, additional, Muzica, Cristina-Maria, additional, and Trifan, Anca, additional
- Published
- 2021
- Full Text
- View/download PDF
24. Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection?
- Author
-
Cojocariu, Camelia, primary, Girleanu, Irina, additional, Trifan, Anca, additional, Olteanu, Andrei, additional, Muzica, Cristina Maria, additional, Huiban, Laura, additional, Chiriac, Stefan, additional, Singeap, Ana Maria, additional, Cuciureanu, Tudor, additional, Sfarti, Catalin, additional, and Stanciu, Carol, additional
- Published
- 2021
- Full Text
- View/download PDF
25. UNUSUAL CAUSE OF OCCULT SMALL-BOWEL BLEEDING.
- Author
-
Singeap, Ana-Maria, Sfarti, Catalin, Vlad, Nutu, Stanciu, Carol, and Trifan, Anca
- Subjects
- *
IRON deficiency anemia , *SMALL intestine , *SYMPTOMS , *OCCULTISM , *CARDIOVASCULAR diseases , *HEART failure - Abstract
Introduction. Suspected small-bowel bleeding may be overt or occult. In the absence of clinically obvious hemorrhagic manifestations, the anemic syndrome secondary to chronic occult loss is often the alarm signal. We present the case of a patient with severe iron deficiency anemia, diagnosed by small-bowel capsule endoscopy (SBCE) with hemorrhagic ileal polyp, with further succesfull surgical solution. Clinical presentation. 74-year-old male patient with significant associated cardiovascular diseases - arterial hypertension, permanent atrial fibrillation, heart failure NYHA class III, undergoing oral anticoagulant therapy. The worsening of the cardiac symptoms lead to the detection of a severe iron deficiency anemia (Hb 6.4/dL), with no overt bleeding. Consequently, the exploration of the gastrointestinal tract was decided. After negative upper gastrointestinal endoscopy, colonoscopy, and abdominal CT examination, SBCE was performed. An irregular sessile protruding lesion, developped on less than a quarter of the circumference, with active bleeding, in the distal third of the small intestine, was seen. Consequently, the surgeon performed a cuneiform ileal resection, with anatomo-pathological result of ulcerated hyperplastic polyp. The immediate and long-term postoperative evolution was favorable, both clinically and biologically, with the amelioration and then remission of the anemia. Conclusions. Infrequent benign tumors, with extremely rare sporadic occurrence, ileal hyperplastic polyps may present with occult hemorrhage as complication, probably having as risk factor the associated anticoagulant treatment, with occult hemorrhage, responsible for severe secondary iron deficiency anemic syndrome. Applying the investigational algorithm for unexplained iron deficiency anemia allows the etiological diagnosis and the application of the curative therapeutic intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2023
26. EXCELLENT NEGATIVE PREDICTIVE VALUE AND TIMEIMPROVED DIAGNOSTIC YIELD OF CAPSULE ENDOSCOPY IN SUSPECTED ISOLATED SMALL BOWEL CROHN'S DISEASE.
- Author
-
Singeap, Ana-Maria, Trifan, Anca, Petrea, Oana, Sfarti, Catalin, Huiban, Laura, Girleanu, Irina, Muzica, Cristina, and Stanciu, Carol
- Subjects
- *
CROHN'S disease , *SMALL intestine , *CAPSULE endoscopy , *INTESTINAL diseases , *GASTROINTESTINAL hemorrhage , *GASTROINTESTINAL system , *CELIAC disease - Abstract
Background. There is no unique diagnostic test for Crohn's disease, and the diagnosis of isolated small bowel Crohn's disease (SBCD) is even more challenging, due to non-patognomonic clinical picture and low availability of accurate exploration methods. Small bowel capsule endoscopy (SBCE) revolutionized the approach of middle gastrointestinal tract, becoming the first investigation tool when small bowel pathology is suspected. Objective of the study. The aim of our study was to assess the value of SBCE in diagnosing isolated SBCD. Materials and Methods. We retrospectively studied the patients undergoing SBCE for suspected isolated SBCD, in a six-year period, including in our analysis only the patients with a minimum one-year follow-up period. We calculated the diagnostic yield of SBCE, defined as number of capsule endoscopy exams whith positive findings, and we also assessed its yearly variation in time over the six-year period. Subsequently, analyzing follow-up data, positive and negative predictive values were assessed. Results. 78 patients were investigated by SBCE for suspected isolated SBCD. SBCE showed lesions compatible with the diagnosis of SBCD in 49 patients, corresponding to a specific diagnostic yield of 62.8%, while for the remaining 29 patients (37.2%), no CD lesions were found. Following additional investigations, three of the 49 patients initially thought as having isolated SBCD were reclassified as SB lymphoma, eosinophilic gastroenteritis and intestinal tuberculosis, respectively, corresponding to a positive predictive value of 93.8%. During followup, none of the 29 patients with negative SBCE was diagnosed with CD, corresponding to a negative predictive value of 100%. We found a progressively increase of the diagnostic yield over time (from 42.6% in the first year to 70.2% in the last year of the analyzed period), corresponding the most probably to the refinement of the indication. Conclusions. Despite a relatively low diagnostic yield, SBCE has a good positive predictive value for isolated SBCD. However, as CE is a purely visual technique with no capability of taking biopsies, final diagnosis needs confirmation by additional investigations. Nevertheless, SBCE has a 100% negative predictive value, being an excellent tool for rulling out isolated SBCD. Refinement of the indication could ensure a better diagostic yield. [ABSTRACT FROM AUTHOR]
- Published
- 2023
27. RISK FACTORS FOR MULTIPLE POTENTIALLY BLEEDING LESIONS IN EMERGENCY UPPER GASTROINTESTINAL ENDOSCOPIES.
- Author
-
Singeap, Ana-Maria, Girleanu, Irina, Cojocariu, Camelia, Huiban, Laura, Muzica, Cristina, Cuciureanu, Tudor, Chiriac, Stefan, Sfarti, Catalin, Stanciu, Carol, and Trifan, Anca
- Subjects
- *
GASTROINTESTINAL hemorrhage , *PEPTIC ulcer , *HEMORRHAGE , *ALCOHOL drinking - Abstract
Introduction. Gastrointestinal bleeding is one of the most important medical-surgical emergencies. Upper gastrointestinal bleeding (UGIB), defined as hemorrhage having its origin above Treitz'angle, is the most frequent type, and is suspected when the patient present with hemethemesis and/or melena. Etiological diagnosis is vital for the patients'prognosis, and it relies mostly on upper gastrointestinal endoscopy (UGIE). However, endoscopy can show more than one bleeding or potentially bleeding lesion. Aim. The objective of our study was to analyze the frequence of multiple potentially bleeding lesions as seen in emergencies upper gastrointestinal endoscopies. Material and Methods. We performed a retrospective study on patients with acute UGIB presented in the Emergency Department of „St. Spiridon" Clinical County Hospital, investigated by UGIE, in the last six months; epidemiological, clinical and biologic data were recorded, as well as the results of UGIE. Furthermore, correlations between the presence of multiple potentially bleeding lesions and clinical and biological factors were made. Results. 480 patients with suspected acute UGIB were investigated by emergency UGIE. The bleeding source was found in 375 (78%) patients; among them, 278 (58%) patients had one single bleeding lesion, while in 97 (14%) patients more than one potentially bleeding lesion was found. For the remaining 105 (22%) patients, no obvious causal lesion were found, and they were further investigated. The most frequent unique lesions were peptic ulcers and gastro-oesophageal varices, while the most encountered associations were Mallory-Weiss syndrome and peptic ulcer, and gastrooesophageal varices and gastro-duodenal ulcer. The factors correlated with the presence of multiple potentially bleeding lesions were: age, alcohol consumption, the presence of cirrhosis and Charleson comorbidity index. Conclusions. Even if in most cases UGIE is diagnostic for UGIB, there are cases when no lesions are found and also cases with more than one potentially bleeding lesion. Older age, the alcohol consumption, cirrhotic patients and the presence of comorbidities are associated with multiple potentially bleeding lesion. Thorough clinical examination and accurate endoscopic exam are mandatory for the right diagnosis and treatment, to ensure the most favorable patients' outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2023
28. TRANSLATION INTO THE CLINICAL PRACTICE OF BAVENO VII CONSENSUS RECOMMENDATIONS.
- Author
-
SINGEAP, ANA-MARIA, Trifan, Anca, Petrea, Oana, Sfarti, Catalin, Huiban, Laura, Girleanu, Irina, Muzica, Cristina, and Stanciu, Carol
- Subjects
- *
GASTROENTEROLOGISTS , *ESOPHAGEAL varices , *PORTAL hypertension , *CHRONICALLY ill , *CARVEDILOL , *MEDICAL screening - Abstract
Background. Specific Baveno VII consensus recommendations are based on the reliability of noninvasive criteria to rull out or rull in clinically significant portal hypertension (CSPH). Aim. We aimed to assess the translation into the real-world clinical practice of the main Baveno VII consensus recommendations. Material and Methods. We launched a brief online survey, and we invited physicians to respond to several questions related to advanced chronic liver disease patients' care (the use of non-invasive criteria to avoid endoscopy when CSPH is rulled out, the prevention of decompensation when CSPH is rulled in, and the type of non-selective beta-blocker). Results. 108 gastroenterologist and hepatologist practitionners answered our survey. According to the type of the medical unit in which they developed their clinical activity, there was an uniform distrubution between municipal, county and universitary hospitals. For clarity and reproducibility, we present the questions and answers as they were originally formulated. Question A. Do you perform an upper gastrointestinal endoscopy for variceal screening to patients with Thrombocyte count <150.000/mmc and liver stiffness measurement < 15 kPa? Answers: 1. Yes: 67 (62%); 2. No: 41 (38%). Question B. Do you initiate non-selective beta-blockers to your patients when liver stifness measurement is more than 25 kPa, for the prevention of the decompensation? Answers: 1. Yes: 99 (85%); 2. No: 9 (15%). Question C. If yes, what NSBB do you prefer? Answer: 1. Carvedilol: 92 (85%); 2. Propranolol: 16 (15%). Conclusions. Baveno VII consensus recommendation regarding avoidance of UGIE in patients with NIT rulling out CSPH is not generally adopted in the clinical practice. The majority of gastroenterologists and hepatologists preffer however performing UGIE, which can be explained by the fear of possibly missing oesophageal varices, and also by the wide acessibility of UGIE in Romania, both in general hospitals, but especially in universitary centers. However, the NSBB (Carvedilol being the most frequently the first choice) are generally recommended by non-invasive criteria, proving the awareness of the practitioners regarding the prevention of decompensation BAVENO VII takeaway message. [ABSTRACT FROM AUTHOR]
- Published
- 2023
29. USEFULNESS OF AGGRESSIVENESS INDEX (AGI) IN ASSESSING THE PATTERN OF HCVRELATED HEPATOCELULLAR CARCINOMA AFTER DIRECT ACTING ANTIVIRALS.
- Author
-
MUZICA, CRISTINA-MARIA, Stanciu, Carol, Huiban, Laura, Girleanu, Irina, Zenovia, Sebastian, Cuciureanu, Tudor, Nastasa, Robert, Rotaru, Adrian, Stafie, Remus, Stratina, Ermina, Chiriac, Stefan, Cojocariu, Camelia, Singeap, Ana Maria, and Trifan, Anca
- Subjects
- *
PORTAL vein , *ANTIVIRAL agents , *HEPATOCELLULAR carcinoma , *HEPATITIS C - Abstract
Introduction. Despite the high efficacy of direct acting antivirals (DAAs) in curing chronic HCV infection, there is a concern regarding a more aggressive phenotype of hepatocellular carcinoma (HCC) after DAA treatment. Although there are many clinical cohort studies that have evaluated the incidence and recurrence of HCC in these patients, data on the tumor characteristics of HCC after DAAs are not sufficient to establish a clear conclusion. A promising index was recently developed for the evaluation of HCC aggressiveness (AGI) which comprises 4 tumor-related parameters: maximum tumor diameter (MTD), number of tumor nodules, portal vein thrombosis (PVT) and serum AFP levels. Aim. We aimed to investigate the usefulness of AGI in assessing the pattern of HCV-related HCC after DAAs and the predictive value in survival. Material&methods. We carried out a retrospective comparative observational study in which we included patients treated with DAAs for HCV infection and diagnosed with HCC in the Institute of Gastroenterology and Hepatology from Iași, Romania, between January 1st, 2017 and December 31, 2019. Patients were matched based on age and sex with a historic cohort consisting of patients with HCV-related HCC without DAA therapy. Based on AGI, patients were divided into three aggressiveness classes: class A (low aggressiveness), B (intermediate aggressiveness) and C (high aggressiveness). Results. Among the 124 patients with chronic HCV infection diagnosed with HCC, 66 (53.2%) patients were males and 58 (46.8%) were female, with a mean age of 62.38 ± 9.88 years. According to DAAtreated and DAA-naive status, patients were divided into 2 groups: the DAA group included 30 treated patients and the non-DAA group included 94 DAAnaive patients. In the DAA group, the frequency of single HCC was much higher (73.3%) than in naïve patients (53.2%) (p = 0.052), as well as smaller tumor sizes (41.07 ± 18.116mm vs. 61.79 ± 34.477mm, p=0.001) and lower rates of malignant PVT (20% vs. 36%, p = 0.146). According to AGI, class B was the most frequently observed (42.6%) in DAA-naïve patients, followed by class A (31.9%) and class C (25.5%), whilst in DAA-treated patients the most frequent was class A (46.7%), closely followed by class B (40.0%), and class C in 13.3% of cases. The 3-year survival probability for AGI class A vs. B vs. C was 66.9% vs 40.2% vs 8.4%; p=0.001, from the time of diagnosis by Kaplan-Meier plot. There was a significantly higher survival rate in the DAA group compared to DAA-naïve patients (75.3% vs. 52.4%, p = 0.008). [ABSTRACT FROM AUTHOR]
- Published
- 2023
30. PRELIMINARY STUDY ON THE APPLICABILITY OF HEPATOCELLULAR CARCINOMA RISK FACTOR SCORE PAGE-B IN DIFFERENT CHRONIC LIVER DISEASES.
- Author
-
Balmus, Ioana Miruna, Robea, Madalina Andreea, Duta, Raluca, Ilie, Ovidiu Dumitru, Muzica, Cristina, Huiban, Laura, Girleanu, Irina, Cojocariu, Camelia, Singeap, Ana-Maria, Stanciu, Carol, and Trifan, Anca
- Subjects
- *
DISEASE risk factors , *LIVER diseases , *FATTY liver , *NON-alcoholic fatty liver disease , *HEPATOCELLULAR carcinoma , *CHRONIC hepatitis C - Abstract
Hepatocellular carcinoma (HCC) is currently the most severe form of liver disease consisting of malignant processes following fibrotic and cirrhotic damage. Despite there are several validated scores for assessing the overall risk to develop HCC in patients diagnosed with chronic liver diseases, most of these are designed for patients with viral hepatitis B and C and subsequently rely on specific measurements, such as viral load or viral profiling. PAGE-B is commonly used to predict HCC risk in patients with viral hepatitis B. In this context, this study aimed to evaluate the applicability of PAGE-B in different liver diseases predisposing to HCC. On a series of 104 consecutive patients, PAGE-B was calculated according to standard guidelines. Based on the collected data, the applicability of PAGE-B was evaluated in several liver pathologies predisposing to HCC, such as alcoholic liver disease, chronic viral hepatitis C, and non-alcoholic fatty liver disease. The mean age of the patients was 67,65 ± 1,15 years, while the sex distribution was 57,28 % males to 42,72 % females. The selected cohort consisted of 11 patients with alcoholic liver disease (10,57 %), 54 patients with chronic viral hepatitis C (51,92 %), and 39 patients with non-alcoholic fatty liver disease (37,5 %). We found that the patients with alcoholic liver disease patients scored highest for PAGE-B (20,09 ± 0,45), while non-alcoholic fatty liver disease patients score lowest (17,89 ± 0,47), significantly different from one another (p = 0,021). In conclusion, our results suggested that PAGE-B could be useful in evaluating HCC risk in chronic liver diseases, but further studies are needed to find a suitable scoring system to predict the overall risk to develop HCC in patients that are diagnosed with nonalcoholic fatty liver disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
31. THE EFFICACY OF USING ORAL SEMAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES AND NONALCOHOLIC FATTY LIVER DISEASE.
- Author
-
Stratina, Ermina, Stanciu, Carol, Nastasa, Robert, Rotaru, Adrian, Stafie, Remus, Zenovia, Sebastian, Sfarti, Catalin, Cojocariu, Camelia, Cuciureanu, Tudor, Muzica, Cristina, Girleanu, Irina, Chiriac, Stefan, Minea, Horia, Singeap, Ana-Maria, Huiban, Laura, and Trifan, Anca
- Subjects
- *
NON-alcoholic fatty liver disease , *TYPE 2 diabetes , *HEPATIC fibrosis , *SEMAGLUTIDE , *BODY mass index - Abstract
Introduction. Non-alcoholic fatty liver disease (NAFLD) is usually associated with type 2 diabetes mellitus (T2DM). The limited number of NAFLD treatment options is well known. Semaglutide, a GLP-1 receptor agonist approved to treat T2DM, is crucial for obtaining a healthy weight. Additionally, may constitute a cutting-edge therapy option for T2DM patients with NAFLD. In this study, liver steatosis and fibrosis in T2DM patients are measured using vibration-controlled transient elastography (VCTE) with controlled attenuation parameter (CAP). Material and Methods. Fifty-seven consecutive patients with T2DM and NAFLD receiving oral semaglutide were enrolled from September 2022 to February 2023 and evaluated by VCTE with CAP. Clinical and analytical data for every subject were recorded. Oral semaglutide was initiated at a dose of 3 mg once daily and subsequently increased to 7 mg at 4 weeks, and 14 mg at 8 weeks in accordance with the diabetologist's recommendations. Results. VCTE analysis showed that 40 diabetic people (70.2%) had significantly lower CAP levels after 24 weeks compared to baseline. Only 14 (24.5%) diabetic patients experienced a significant decrease in liver fibrosis. Regarding body mass index (BMI), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), have improved significantly compared to the baseline (mean BMI 28.72±5.43 kg/m2 to 25.67 ±6.11 kg/m2, mean AST 58.17 ± 16.33 IU/L to 34.54 ± 13.8 IU/L, mean ALT 63.31 ± 12.66 IU/L to 39.17 ± 14.3 IU/L). The mean hemoglobin A1c (HbA1c) value reduced significantly from baseline to 24 weeks (from 8.9% to 7.4%). A significant correlation existed between changes in CAP values and fasting plasma glucose (p=0.31, p=0.52), as well as AST (p=0.188, p=0.48), and BMI (p=0.274, p=0.44). Nausea and diarrhea were the most often reported side effects. Conclusion. In individuals with T2DM with NAFLD, oral semaglutide therapy has improved glycemic control, liver enzymes, body weight, and liver steatosis. These findings suggest that semaglutide may be useful in the treatment of NAFLD patients, therefore more studies concerning liver fibrosis are necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2023
32. NON-ALCOHOLIC FATTY LIVER DISEASE - A COMMON FINDING AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
- Author
-
Stafie, Remus-Theodor, Rotaru, Adrian, Stanciu, Carol, Zenovia, Sebastian, Stratina, Ermina, Nastasa, Robert, Minea, Horia, Singeap, Ana Maria, Cojocariu, Camelia, Sfarti, Catalin, Girleanu, Irina, Chiriac, Stefan, Cuciureanu, Tudor, Huiban, Laura, Muzica, Cristina, and Trifan, Anca
- Subjects
- *
NON-alcoholic fatty liver disease , *INFLAMMATORY bowel diseases , *FATTY liver , *DISEASE risk factors , *HEPATIC fibrosis , *MYOCARDIAL infarction , *SYSTOLIC blood pressure - Abstract
Background and Aims. Inflammatory bowel diseases (IBD) are caused by a dysregulated immune response in the hosts, favored by genetic susceptibility. In addition to symptoms related to the digestive tract, about 40% of patients with IBD also experience extraintestinal manifestations. Although, non-alcoholic fatty liver disease (NAFLD) has been frequently associated with IBDs, the relationship between these two pathologies remains unclear. The aim of this study was to investigate the prevalence of NAFLD among IBD patients, as well as the factors that connect these two conditions. Material and methods. From January 2022 to November 2022, consecutive IBD patients were enrolled from a tertiary care center hospital in Iasi. Patients' demographic information, clinical characteristics including blood pressure, biological parameters, and anthropometric measurements were collected. Following informed consent, participants underwent a fibroscan evaluation for liver stiffness measurement (LSM) and controlled attenuation parameter (CAP). Results. 93 patients with IBD were enrolled (65,3% men, 55,6% with ulcerative colitis). 45 (48,3%) of them were diagnosed with NAFLD, with a mean CAP score of 283 ± 33.4 vs. 215 ± 23.7 in patients with IBD only. Regarding liver fibrosis, mean LSM value in the NAFLD group was 6.8 ± 1.9 kPa vs. 5.7 ± 2.3 kPa in the non-NALFD group. Subjects with NAFLD exhibited higher body mass indexes than those with IBD only (26.2 vs. 33.1, p<0.05). In addition, the prevalence of diabetes was much greater among this group (27.5% vs. 0%; p=0.0001), as was the prevalence of elevated HbA1c levels in the absence of a diabetes diagnosis (14% vs. 7.35%; p=0.23). They also had a non-significantly higher mean systolic blood pressure and greater incidences of hypertension. Compared to those without NAFLD, the NAFLD cohort had higher rates of diagnosed hypercholesterolaemia, were older with a higher mean disease duration and had a higher nonsignificant level of triglycerides. The 10-year risk of myocardial infarction or death estimated by the Framingham risk scores for hard coronary heart disease was higher in the NAFLD group (2.32% vs. 4.27%, p=0.0024). Conclusions. NAFLD is a multifaceted condition that is becoming more common in IBD patients. Although the present evidences in the literature suggest a small risk for the advance of liver fibrosis, the cardiovascular risk seems to be of a greater interest. Considering the above data, patients with IBD should be evaluated with a multidisciplinary approach. [ABSTRACT FROM AUTHOR]
- Published
- 2023
33. APPARENTLY FIT BUT NOT HEALTHY - HIGH CARDIOVASCULAR RISK IN LEAN NAFLD PATIENTS.
- Author
-
Rotaru, Adrian, Stafie, Remus, Stanciu, Carol, Zenovia, Sebastian, Stratina, Ermina, Nastasa, Robert, Minea, Horia, Singeap, Ana-Maria, Cojocaru, Camelia, Sfarti, Catalin, Girleanu, Irina, Chiriac, Stefan, Cuciureanu, Tudor, Huiban, Laura, Muzica, Cristina, and Trifan, Anca
- Subjects
- *
HEPATIC fibrosis , *NON-alcoholic fatty liver disease , *CARDIOVASCULAR diseases risk factors , *SYSTOLIC blood pressure , *TYPE 2 diabetes - Abstract
Background and Aims. Non-alcoholic fatty liver disease (NAFLD) and obesity are independently related to an increased risk for atherosclerotic cardiovascular disease (ASCVD), the primary cause of mortality in NAFLD patients. Even though many subjects with NAFLD are normal weight, it still remains uncertain whether their ASCVD risk is of major importance. The aim of this study is to assess and compare the ASCVD risk between lean and obese patients with NAFLD. Methods. Normal weight and obese patients were evaluated between January 2020 and February 2023 and their data was analyzed. NAFLD was diagnosed by vibration-controlled transient elastography (VCTE) with controlled attenuation parameter (CAP) and the American College of Cardiology/American Heart Association guidelines was used to evaluate the ASCVD risk. Results. In the obese group, 104 (63.8%) patients were diagnosed with NAFLD, compared to 32 (12.3%) in the lean population. In comparison to those with obese NAFLD, subjects with lean NAFLD had significantly higher ASCVD scores (mean 15.3% vs 22.7%, p<0.001). Moreover, subjects with lean NAFLD and significant liver fibrosis had a higher risk of ASCVD events, compared to their obese counterparts (OR, 2.51 vs 1.95, p=0.034). Regarding the presence of the components of the metabolic syndrome, the prevalence of type 2 diabetes mellitus was higher the obese group, while changes in the lipid profile and higher systolic blood pressure were more frequently found in lean subjects. Conclusions: Subjects with lean NAFLD had an ASCVD score that were significantly higher than those with obese NAFLD. In both study groups, the presence of significant liver fibrosis was an essential risk factor associated with an ASCVD event, but the effects were more pronounced in lean individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2023
34. THE AWARENESS OF MEDICAL WORKERS AND STUDENTS REGARDING THE ARTIFICIAL INTELLIGENCE-BASED SOLUTIONS USE IN MEDICINE.
- Author
-
Robea, Mădălina Andreea, Balmuș, Ioana-Miruna, Duță, Raluca, Ilie, Ovidiu-Dumitru, Minea, Horia, Muzica, Cristina, Huiban, Laura, Girleanu, Irina, Cojocaru, Camelia, Singeap, Ana-Maria, Stanciu, Carol, and Trifan, Anca
- Subjects
- *
ARTIFICIAL intelligence , *MEDICAL personnel , *MEDICAL care research , *TASK analysis , *MEDICAL care , *INTERPROFESSIONAL education - Abstract
The latest technological progress provided significant changes in the approach of several areas of daily life, healthcare, and research. In this context, there are many solutions based on artificial intelligence (AI) that were designed to provide assistance in repetitive, ultraprecision, and high-performance data analysis tasks. While the benefits of using AI in Medicine are suggestive, they are shadowed by potential limitations based on the perception of the targeted users due to lack of awareness, mistrust, and human versus machine controversy. Thus, we aimed to find the current opinion of the medical workers and students regarding the modern applications of AI in medical care and research. Using an online specialised platform, we conducted a survey addressed to the members of academic and healthcare community. They were invited to answer specific questions evaluating their knowledge on AI, and their availability to accept and use AI-based applications in daily life and profession. Also, they were challenged to identify advantages and weaknesses of AI-based applications in healthcare and medical research. We found that the responses regarding the use of AI-based solutions in daily life and healthcare suggested several differences in awareness. Also, some of the participants identified several possible sources of inequity in receiving medical care when intelligence-based applications were used in decision making demarche. Similarly, despite that AI-based resources could offer high performance solutions to medical care and research consequent to technology progress, the participants pointed out that the main negative outcome of artificial would be the lack of empathy involved in patients' management. AI-based solutions in medical care could offer significant improvements of the medical act and in biomedical research. However, there are still many limitations that should be addressed when adapting AI resources in Medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2023
35. EVALUATION OF LIVER FIBROSIS IN INDIVIDUALS WITH METABOLIC SYNDROME USING NON-INVASIVE TESTS.
- Author
-
Nastasa, Robert-Radu, Stanciu, Carol, Zenovia, Sebastian, Stafie, Remus, Stratina, Ermina, Rotaru, Adrian, Singeap, Ana-Maria, Cojocariu, Camelia, Sfarti, Catalin, Girleanu, Irina, Chiriac, Stefan, Cuciureanu, Tudor, Huiban, Laura, Muzica, Cristina, Minea, Horia, and Trifan, Anca
- Subjects
- *
HEPATIC fibrosis , *FATTY liver , *NON-alcoholic fatty liver disease , *METABOLIC syndrome , *NONINVASIVE diagnostic tests , *ASPARTATE aminotransferase - Abstract
Introduction. Metabolic syndrome (MS) patients are at increased risk for severe liver fibrosis and nonalcoholic fatty liver disease. However, there aren't any recommendations until this moment for screening MS patients. This study aimed to evaluate the diagnostic precision of non-invasive tests in identifying advanced liver fibrosis (F3) and cirrhosis (F4) in MS patients using vibration-controlled transient elastography (VCTE) as a standard quantification method. Materials and Methods. Between September 2022 to March 2023, we prospectively enrolled MS patients at the Gastroenterology and Hepatology Institute Iasi who had undergone evaluation using noninvasive tests like the aspartate aminotransferase to platelet ratio index (APRI) score, fibrosis-4 (FIB-4) index, and NAFLD fibrosis score (NFS). When compared to liver stiffness measures (LSM), we assessed the specificity, sensitivity, negative predictive value (NPV), and positive predictive value (PPV) for each of these indicators in the identification of at least advanced liver fibrosis (=F3). Results. Of the 116 MS patients included in this study, who had a mean BMI of 27.82±4.62 kg/m2 and at least three metabolic conditions, 69 individuals (59.5%) were females. Using a cut-off of 9.7 kPa, 35 (30.2%) patients had at least advanced fibrosis (=F3) according to LSM measurements. VCTE examinations present a higher correlation with the FIB-4 index (r=0.566), NFS (r=0.585), and APRI score (r=0.624) (p< 0.001). The NPV for the FIB-4 index was the highest (90.38%), followed by the NPV for the NFS score (87.84%). The main result of our research showed that all the biomarkers had reasonably high NPV (>85%) and accuracy (>83%) for predicting advanced liver fibrosis, with moderate specificity (80%) and PPV (75%). Conclusion. To prevent progressive fibrosis in MS patients, the FIB-4 index and NFS score seem to be the most suitable surrogate VCTE biomarkers. It may be necessary to take action and further evaluation of liver fibrosis in a tertiary care center for populations at risk after these non-invasive and affordable screening tests are used in primary care settings. [ABSTRACT FROM AUTHOR]
- Published
- 2023
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.